Table 3.
Association of genotype and clinicopathological parameters in NPC patientsa
| Genotype | ||||
|---|---|---|---|---|
| Characteristics | TT | TC | CC | P |
| Age | ||||
| <45 | 39 (60%) | 21 (32%) | 5 (8%) | 0.368 |
| ≥45 | 39 (50.6%) | 27 (35.1%) | 11 (14.3%) | |
| Gender | ||||
| Male | 55 (52.4%) | 36 (34.2%) | 14 (13.4%) | 0.362 |
| Female | 23 (62.2%) | 12 (34.4%) | 2 (5.4%) | |
| Primary tumor extension | ||||
| T1 + T2 | 28 (53.9%) | 17 (32.7%) | 7 (13.4%) | 0.819 |
| T3 + T4 | 50 (55.6%) | 31 (34.4%) | 9 (10%) | |
| Lymph node status | ||||
| N0 | 9 (81.8%) | 1 (9.1%) | 1 (9.1%) | 0.151 |
| N1 + N2 + N3 | 69 (52.6%) | 47 (35.9%) | 15 (11.5%) | |
| Metastasis | ||||
| No | 65 (52.9%) | 43 (34.9%) | 15 (12.2%) | 0.408 |
| Yes | 13 (68.4%) | 5 (26.4%) | 1 (5.2%) | |
a
Data available only in 142 cases.